Ontogenesis of κ-opioid receptors in rat brain using [3H]U-69593 as a binding ligand

doi:10.1016/0014-2999(90)90157-2

European Journal of Pharmacology

Volume 175, Issue 1, 3 January 1990, Pages 93-96

https://doi.org/10.1016/0014-2999(90)90157-2 Get rights and content

Abstract

The ontogenesis of κ-opioid receptors has been studied in the postnatal period from day 5 to day 30 using the highly selective κ-site ligand [³H]U-69593 in binding studies. Analyses of saturation curves revealed a marked increase in the binding capacities between day 5 and day 10 with no further increment in the number of sites up to adult ages confirming a distinct ontogenetic profile from μ- and δ-sites. When expressed per mg protein the number of sites declined from day 10 to adult. At all postnatal ages there was little change in receptor affinity. This ontogenetic profile is broadly in agreement with studies using non-selective κ-ligands but the number of sites labelled by [³H]U-69593 is markedly lower in both the neonate and the adult.

References (11)

G.A. Barr et al.
κ-Opioid receptor mediated analgesia in the developing rat
Dev. Brain
(1986)
H.F. Hill et al.
Differential postnatal ontogeny of opiate and benzodiazepine receptor subtypes in rat cerebral cortex: binding characteristics of trifluadom and brotizolam
Jap. J. Pharmacol.
(1984)
R.A. Lahti et al.
[³H]U-469593, a highly selective ligand for the κ-opioid receptor
European J. Pharmacol.
(1985)
J. McDowell et al.
Ontogenesis of δ-opioid receptors in rat brain using [³H]D-Pen²,D-Pen⁵]enkephalin as a binding ligand
European J. Pharmacol.
(1986)
J. McDowell et al.
Development of opioid systems: peptides, receptors and pharmacology
Br. Rev. Res.
(1987)

There are more references available in the full text version of this article.

Cited by (25)

Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G
2012, Neuroscience
Citation Excerpt :
All other reagent-grade chemicals were obtained from Sigma Chemical Co (St. Louis, MO, USA) or Fisher Scientific (Pittsburgh, PA, USA). These experiments were performed as described by Kitchen and colleagues (Kitchen et al., 1990; Slowe et al., 1999). Animals were killed by decapitation, and brains were removed and immediately immersed in isopentane in a stainless steel beaker on dry ice.
OPRM1 A118G is a common single nucleotide polymorphism (SNP) in the coding region of the human mu opioid receptor (MOPR) gene OPRM1. This SNP is associated with higher morphine doses required for postoperative analgesia as well as a variety of drug addiction phenotypes. A mouse model possessing the equivalent substitution (A112G) in the Oprm1 gene was generated to facilitate mechanistic studies. Mice homozygous for the G112 allele (G/G) displayed lower antinociception to morphine compared with those homozygous for A112 allele (A/A), similar to humans, suggesting that the mice are a good model to further characterize underlying factors contributing to phenotypes associated with this SNP. Here, we compared [³H]DAMGO binding to the MOPR in the brains of A/A and G/G mice using quantitative in vitro autoradiography. A/A mice exhibited higher [³H]DAMGO binding than G/G in the cingulate, motor, and insular cortices, nucleus accumbens core and shell, hypothalamus, thalamus, amygdala, periaqueductal gray, superficial gray of superior colliculus, and ventral tegmental area. No genotype differences were observed in somatosensory cortex, caudate putamen, and hippocampus. When males and females were examined separately, A/A mice showed higher [³H]DAMGO binding than G/G mice in more brain regions in males than in females. Radioligand binding using brain membranes also showed higher [³H]DAMGO binding in the cortex and thalamus in A/A mice than G/G mice but no genotype differences in the caudate putamen or hippocampus. Thus, the A112G SNP is associated with reduced MOPR expression in some, but not all, brain regions, and appears to have some sex differences. The elevated MOPR expression in periaqueductal gray and thalamus in A/A mice are consistent with their higher antinociceptive responses to morphine. The higher MOPR levels in nucleus accumbens and/or ventral tegmental area of A/A mice is consistent with the higher morphine-induced hyperactivity and locomotor sensitization observed in these mice. Thus, these results provide some insights into the observed decreased clinical opioid potency in humans with the A118G SNP.
Induction of the mouse κ-opioid receptor gene by retinoic acid in p19 cells
2002, Journal of Biological Chemistry
The mouse κ-opioid receptor (KOR) gene is expressed in mouse embryonal carcinoma P19 cells and induced by retinoic acid (RA) within 24 h. An RA-responsivecis-acting element is identified within promoter I of the KOR gene. This element contains a GC box, a putative binding site for transcription factor Sp1. Enhanced binding of Sp1 to this GC box correlates with RA induction of KOR gene. Phosphatase inhibitor (sodium pyrophosphate) decreases RA induction of this promoter, whereas hypophosphorylation of Sp1 results in an increase in its DNA binding affinity to this promoter as demonstrated by in vitro gel retardation and in vivo chromatin immunoprecipitation assays. Consistently, the inhibitor of MEK, PD98058, dose-dependently enhances RA induction of this promoter, suggesting that the ERK signaling pathway is negatively involved in the RA induction of mouse KOR gene activities. Collectively, enhanced binding of Sp1 to promoter I of the KOR gene as a result of inhibiting the ERK pathway contributes to RA induction of this gene in P19.
Prenatal morphine exposure alters estrogen regulation of κ receptors in the cortex and POA of adult female rats but has no effects on these receptors in adult male rats
2001, Brain Research
The binding characteristics of κ receptors were assessed in the frontal cortex (CX), striatum, hypothalamus, preoptic area (POA), cerebellum, and ventral tegmental area of adult male and female rats exposed prenatally to morphine or saline. Prenatal morphine exposure altered estrogen regulation of κ receptors in the CX and POA of females, but had no effects on κ receptors in any of the examined brain regions in male rats.
An Intronic Ikaros-binding Element Mediates Retinoic Acid Suppression of the Kappa Opioid Receptor Gene, Accompanied by Histone Deacetylation on the Promoters
2001, Journal of Biological Chemistry
The mouse kappa opioid receptor (KOR) gene is constitutively expressed in mouse embryonal carcinoma P19 stem cells and suppressed by retinoic acid (RA) in cells undergoing neuronal differentiation. A negative regulatory element is located within intron 1 of the KOR gene, which contains an Ikaros (Ik)-binding site (GGGAAgGGGAT). This sequence is an Ik-1 respondive, functionally negative element as demonstrated in the context of both natural KOR and heterologous promoters. The two underlined G residues of the second half-site are critical for Ik-1 binding and Ik-mediated repression of the KOR gene. RA induces Ik-1 expression within 1 day of treatment and suppresses KOR expression between 2 and 3 days. Overexpression of Ik-1 in P19 suppresses endogenous KOR gene expression, accompanied by increased binding of Ik-1 to the Ik-binding site and chromatin histone deacetylation on KOR promoters. It is proposed that in an RA-induced P19 differentiation model, RA elevates Ik-1 expression, which recruits histone deacetylase to intron 1 of the KOR gene and silences KOR gene promoters.
Prenatal exposure to morphine differentially alters gonadal hormone regulation of δ-opioid receptor binding in male and female rats
2000, Brain Research Bulletin
The present study tested the hypothesis that exposure to morphine on gestation days 11–18 differentially alters δ-opioid receptors in the brain of adult male and female rats. In Experiment 1, the binding characteristics of δ-opioid receptors were examined in membrane homogenates from six brain regions, including the hypothalamus (HYP), preoptic area, frontal cortex (CX), ventral tegmental area, striatum (STR) and cerebellum of adult male and female rats. In Experiment 2, the density of δ-opioid receptors was assessed in the CX and STR using receptor autoradiography. Prenatal morphine exposure has no effects on δ-opioid receptors in the brain of gonadally intact, adult male rats regardless of methodology. However, when male rats were gonadectomized in Experiment 2, morphine-exposed males have fewer δ-opioid receptors than controls in the CX but not in the STR. These reductions in cortical δ-opioid receptors are restored by testosterone replacement, demonstrating that prenatal morphine exposure alters testosterone regulation in the CX of male rats. In ovariectomized (OVX) female rats, prenatal morphine exposure increases the density of δ-opioid receptors in the frontal CX. Interestingly, this up-regulation of δ-opioid receptors is not present when the CX is investigated by autoradiography. Moreover, progesterone given alone or in combination with estrogen reduces the density of δ-opioid receptors in the CX and STR of both saline- and morphine-exposed, OVX females. Thus, mid to late gestational morphine exposure differentially alters the influence of adult gonadal hormones on δ-opioid receptors in the CX, decreasing the sensitivity in females and increasing it in males. This is also the first report to demonstrate that gonadal hormones regulate δ receptor densities in brain regions other than the HYP of OVX females.
Promoter activity of mouse κ opioid receptor gene in transgenic mouse
1999, Molecular Brain Research
The biological activity of mouse κ opioid receptor (KOR) gene promoter was examined in transgenic mice using a β-galactosidase (lacZ) reporter strategy for the first time. A lacZ cDNA was inserted at the 5th amino acid in the coding region of a mouse KOR genomic segment containing 3 kb of the 5′ regulatory region, to generate a Kor-lacZ fusion gene which was then used to generate transgenic mice. The expression of transgene was demonstrated at the RNA level by reverse transcription-polymerase chain reaction (RT-PCR), and at the protein level by in situ lacZ enzyme assay. From studying three independent transgenic mouse lines that express this transgene, it is concluded that Kor-lacZ expression begins at embryonic day 9.5 (E9.5) and increases in several brain areas and neural tube as embryos develop. At E12.5 and E13.5, Kor-lacZ expression is found primarily in the mantle layer of midbrain, hindbrain and medulla oblongata, cranial ganglion and vagus nerve. At E15.5 and E17.5, the transgene is expressed in eye, ear, neopallial cortex, caudate putamen, lateral ventricle, thalamus, hypothalamus and pons. Therefore, the 3 kb 5′ regulatory sequence of the mouse KOR gene is functional in transgenic animals and directs a specific expression pattern recapitulating that of the endogenous KOR gene expression during developmental stages. However, in adult animals, this transgene is only expressed in the brain, indicating that the regulatory information for peripheral expression in the adult is not encoded within this 3 kb upstream sequence.

View all citing articles on Scopus

¹: Present address: Departamento de Biologia animal II, Universidad Complutense, Madrid, Spain.

View full text

Short communicationOntogenesis of κ-opioid receptors in rat brain using [3H]U-69593 as a binding ligand

Abstract

Dev. Brain

Jap. J. Pharmacol.

European J. Pharmacol.

European J. Pharmacol.

Br. Rev. Res.

Short communication
Ontogenesis of κ-opioid receptors in rat brain using [³H]U-69593 as a binding ligand